文献速递乳腺US

利用三维能量多普勒超声成像中的血流特征预测接受新辅助化疗患者的完全缓解

Using Flow Characteristics in Three-Dimensional Power Doppler Ultrasound Imaging to Predict Complete Responses in Patients Undergoing Neoadjuvant Chemotherapy.
PubMed 文献 · J Ultrasound Med · 2017-01-21

研究纳入31例接受新辅助化疗、肿瘤2至5厘米的乳腺癌患者,用三维能量多普勒超声高清晰血流成像获取肿瘤血流/容积指标,结合支持向量机分类预测病理完全缓解。首次化疗前预测准确率83.87%(AUC=0.6957),第二次化疗后准确率87.9%(AUC=0.756);趋势分析显示良好与不良缓解者的血管血流变化趋势不同。

要点

  • 首次化疗前三维能量多普勒超声预测pCR准确率83.87%,AUC=0.6957。
  • 第二次化疗后预测准确率87.9%,AUC=0.756。
  • 良好与不良缓解者在化疗期间血管血流变化趋势不同。

核心结论

  • 这项初步研究证明利用乳腺肿瘤内血管血流预测化疗疗效是可行的。

研究设计与样本

  • 研究纳入31例接受新辅助化疗且肿瘤2至5厘米的乳腺癌患者,采用三维能量多普勒超声高清晰血流成像技术获取肿瘤血流/容积指标,建立化疗反应预测并行支持向量机分类。

关键影像表现/征象

  • 以乳腺肿瘤内血管的实性定向血流作为病理完全缓解(pCR)的标志物。
  • 良好缓解者与不良缓解者在化疗期间血管血流呈现不同的变化趋势。

诊断标准与关键数值

  • 首次化疗前预测pCR的准确率为83.87%,AUC=0.6957。
  • 第二次化疗后预测pCR的准确率为87.9%,AUC=0.756。

局限性

  • 原文称本研究为初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Strategies are needed for the identification of a poor response to treatment and determination of appropriate chemotherapy strategies for patients in the early stages of neoadjuvant chemotherapy for breast cancer. We hypothesize that power Doppler ultrasound imaging can provide useful information on predicting response to neoadjuvant chemotherapy.

METHODS: The solid directional flow of vessels in breast tumors was used as a marker of pathologic complete responses (pCR) in patients undergoing neoadjuvant chemotherapy. Thirty-one breast cancer patients who received neoadjuvant chemotherapy and had tumors of 2 to 5 cm were recruited. Three-dimensional power Doppler ultrasound with high-definition flow imaging technology was used to acquire the indices of tumor blood flow/volume, and the chemotherapy response prediction was established, followed by support vector machine classification.

RESULTS: The accuracy of pCR prediction before the first chemotherapy treatment was 83.87% (area under the ROC curve [AUC] = 0.6957). After the second chemotherapy treatment, the accuracy of was 87.9% (AUC = 0.756). Trend analysis showed that good and poor responders exhibited different trends in vascular flow during chemotherapy.

CONCLUSIONS: This preliminary study demonstrates the feasibility of using the vascular flow in breast tumors to predict chemotherapeutic efficacy.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Shia WC, Huang YL, Wu HK, et al. Using Flow Characteristics in Three-Dimensional Power Doppler Ultrasound Imaging to Predict Complete Responses in Patients Undergoing Neoadjuvant Chemotherapy. J Ultrasound Med. 2017. PMID: 28109009. doi:10.7863/ultra.16.02078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。